The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Distinct Multiple RET/PTC Gene Rearrangements in Multifocal Papillary Thyroid Neoplasia1
Abstract
Rearrangements involving the RET protooncogene have been implicated in the development of papillary thyroid carcinoma (PC). Transgenic mice, expressing thyroid-targeted RET/PTC-1, develop PC; but the clinical significance of this oncogene remains uncertain. We examined the expression of RET/PTC-1, -2, and -3 in human thyroid microcarcinomas and clinically evident PC to determine its role in early stage vs. developed PC and to examine the diversity of RET/PTC in multifocal disease. RNA was extracted from paraffin-embedded microcarcinomas and clinically evident PCs; the results obtained from paraffin-embedded tissue were confirmed on RNA from corresponding snap-frozen tissue of clinically evident PCs. RT and PCR was performed using primers for RET/PTC-1, -2, and -3; PGK-1 (the housekeeping gene) analysis was used to ensure integrity of the RNA and efficiency of the RT reaction. PCR products were resolved by gel electrophoresis, and Southern hybridization was performed with RET/PTC-1, -2, and -3 probes. A polyclonal antibody to the carboxyterminus of RET was used for immunohistochemistry on paraffin sections. Thirty-nine occult papillary thyroid microcarcinomas from 21 patients were analyzed. Of the 30 tumors (77%) positive for RET/PTC rearrangements, 12 were positive for RET/PTC-1, 3 for RET/ PTC-2, 6 for RET/PTC-3, and 9 for multiple RET/PTC oncogenes. In clinically evident tumors, 47% had RET/PTC rearrangements. Immunohistochemistry demonstrated close correlation with RT-PCR-derived findings. RET/PTC expression is highly prevalent in microcarcinoma and occurs more frequently than in clinically evident PC (P < 0.005). Multifocal disease, identified in 17 of the 21 patients, exhibited identical RET/PTC rearrangements within multiple tumors in only 2 patients; the other 15 patients had diverse rearrangements in individual tumors. Our results indicate that RET/PTC oncogene rearrangements may play a role in early-stage papillary thyroid carcinogenesis, but they seem to be less important in determining progression to clinically-evident disease. In multifocal disease, the diversity of RET/PTC profiles, in the majority of cases, suggests that individual tumors arise independently in a background of genetic or environmental susceptibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grieco, M., Santoro, M., Berlingieri, M. T., Melillo, R. M., Donghi, R., Bongarzone, I., Pierotti, M. A., Della Ports, G., Fusco, A., & Vecchiot, G. (1990) · Cell · doi:10.1016/0092-8674(90)90659-3 · Cited by 959
Occult papillary carcinoma of the thyroid. A “normal” finding in finland. A systematic autopsy study
Harach, H. R., Franssila, K. O., & Wasenius, V.-M. (1985) · Cancer · doi:10.1002/1097-0142(19850801)56:3<531::aid-cncr2820560321>3.0.co;2-3 · Cited by 945
Nikiforov, Y. E., Rowland, J. M., Bove, K. E., Monforte-Muñoz, H., & Fagin, J. A. (1997) · PubMed · Cited by 666
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
Fagin, J. A., Matsuo, K., Karmakar, A., Chen, D. L., Tang, S. H., & Koeffler, H. P. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116168 · Cited by 649
A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases
Fusco, A., Grieco, M., Santoro, M., Berlingieri, M. T., Pilotti, S., Pierotti, M. A., Porta, G. D., & Vecchio, G. (1987) · Nature · doi:10.1038/328170a0 · Cited by 413
Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
Santoro, M., Carlomagno, F., Hay, I. D., Herrmann, M. A., Grieco, M., Melillo, R., Pierotti, M. A., Bongarzone, I., Della Porta, G., & Berger, N. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115743 · Cited by 390
Santoro, M. M., Dathan, N. A., Berlingieri, M. T., Bongarzone, I., Paulin, C., Grieco, M., Pierotti, M. A., Vecchio, G., & Fusco, A. (1994) · PubMed · Cited by 366
Klugbauer, S., Lengfelder, E., Demidchik, E. P., & Hm, R. (1995) · PubMed · Cited by 316
Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas
Jhiang, S. M. (1996) · Endocrinology · doi:10.1210/en.137.1.375 · Cited by 314
Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas.
Renzo, M. F. D., Olivero, M., Ferro, S., Prat, M., Bongarzone, I., Pilotti, S., Belfiore, A., Costantino, A., Vigneri, R., & Pierotti, M. A. (1992) · PubMed · Cited by 312
High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma.
Bongarzone, I., Pierotti, M. A., Monzini, N., Mondellini, P., Manenti, G., Donghi, R., Pilotti, S., Grieco, M., Santoro, M., & Fusco, A. (1989) · PubMed · Cited by 287
Expression of the RET/PTC Fusion Gene as a Marker for Papillary Carcinoma in Hashimoto's Thyroiditis
Wirtschafter, A., Schmidt, R., Rosen, D., Kundu, N., Santoro, M., Fusco, A., Multhaupt, H., Atkins, J. P., Rosen, M. R., Keane, W. M., et al. (1997) · The Laryngoscope · doi:10.1097/00005537-199701000-00019 · Cited by 257
RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
Viglietto, G., Chiappetta, G., Martínez-Tello, F. J., Fukunaga, F., Tallini, G., Rigopoulou, D., Visconti, R., Mastro, A., Santoro, M., & Fusco, A. (1995) · PubMed · Cited by 248
Bongarzone, I., Monzini, N., Borrello, M. G., Carcano, C., Ferraresi, G., Arighi, E., Mondellini, P., Della Porta, G., & Pierotti, M. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.358-366.1993 · Cited by 236
Parma, J., Duprez, L., Van Sande, J., Hermans, J., Rocmans, P., Van Vliet, G., Costagliola, S., Rodien, P., Dumont, J. E., & Vassart, G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4144 · Cited by 235
Santoro, M., Chiappetta, G., Cerrato, A., Salvatore, D., Zhang, L., Manzo, G., Picone, A., Portella, G., Santelli, G., Vecchio, G., et al. (1996) · PubMed · Cited by 234
Pierotti, M. A., Santoro, M., Jenkins, R. B., Sozzi, G., Bongarzone, I., Grieco, M., Monzini, N., Miozzo, M., Herrmann, M. A., & Fusco, A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1616 · Cited by 224
Sugg, S. L., Zheng, L., Rosen, I. B., Freeman, J. L., Ezzat, S., & Asa, S. L. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784097 · Cited by 146
Self-citationDetection of the PTC/retTPC oncogene in human thyroid cancers.
Sm, J., Caruso, D. R., Gilmore, E., Ishizaka, Y., Tahira, T., Nagao, M., Chiu, I. M., & Mazzaferri, E. L. (1992) · PubMed · Cited by 138
Klugbauer, S., Demidchik, E. P., Lengfelder, E., & Hm, R. (1998) · PubMed · Cited by 128
Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer.
Mirchandani, D., Zheng, J., Miller, G. J., Ghosh, A. K., Shibata, D. K., Côté, R. J., & Roy‐Burman, P. (1995) · Europe PMC (PubMed Central) · Cited by 120
Fink, A. K., TOMLINSON, G. A., Freeman, J. L., Rosen, I. B., & Asa, S. L. (1996) · PubMed · Cited by 109
Self-citationThe ret/PTC oncogene in papillary thyroid carcinoma.
Sm, J., & Mazzaferri, E. L. (1994) · PubMed · Cited by 109
Prevalence of Activating ras Mutations in Morphologically Characterized Thyroid Nodules
Ezzat, S., Zheng, L., KOLENDA, J., SAFARIAN, A., Freeman, J. L., & Asa, S. L. (1996) · Thyroid · doi:10.1089/thy.1996.6.409 · Cited by 98
Self-citationClonal Origin of Toxic Thyroid Nodules with Constitutively Activating Thyrotropin Receptor Mutations
Krohn, K., Führer, D., Holzapfel, H., Paschke, R., & Führer‐Sakel, D. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.130 · Cited by 87
The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2
Minoletti, F., Butti, M. G., Coronelli, S., Miozzo, M. R., Sozzi, G., Pilotti, S., Tunnacliffe, A., Pierotti, M. A., & Bongarzone, I. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870110108 · Cited by 70
Klugbauer, S., Lengfelder, E., Demidchik, E. P., & Hm, R. (1996) · PubMed · Cited by 68
In vitro reconstruction of tumour initiation in a human epithelium.
Bond, J. A., Wyllie, F. S., Rowson, J., Radulescu, A., & Wynford‐Thomas, D. (1994) · PubMed · Cited by 61
Hosal, S. A., Apel, R. L., Freeman, J. L., Azadian, A., Rosen, I. B., LiVolsi, V. A., & Asa, S. L. (1997) · Endocrine Pathology · doi:10.1007/bf02739704 · Cited by 46
Self-citationIn vitro models of thyroid cancer.
Wynford‐Thomas, D. (1993) · PubMed · Cited by 19
Cited by
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
Mazzaferri, E. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1447 · Cited by 1,396
Pathogenetic mechanisms in thyroid follicular-cell neoplasia
Kondo, T., Ezzat, S., & Asa, S. L. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1836 · Cited by 893
Self-citationAdeniran, A. J., Zhu, Z., Gandhi, M., Steward, D. L., Fidler, J. P., Giordano, T. J., Biddinger, P. W., & Nikiforov, Y. E. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000176432.73455.1b · Cited by 495
RET/PTC Rearrangement in Thyroid Tumors
Nikiforov, Y. E. (2002) · Endocrine Pathology · doi:10.1385/ep:13:1:03 · Cited by 489
RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors
de Groot, J. W. B., Links, T. P., Plukker, J. T. M., Lips, C. J. M., & Hofstra, R. M. W. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0017 · Cited by 356
Metadata
- Authors
- Sugg, S. L., Ezzat, S., Rosen, I. B., Freeman, J. L., & Asa, S. L.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1998-11
- Volume
- 83
- Issue
- 11
- Pages
- 4116-4122
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2059964515
- Cited by
- 273
- References
- 30
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.